...3 Years Later Increased risk for adverse cardiovascular outcomes and invasive breast cancer — and reduced risk for fractures and colorectal cancer — did not persist after women discontinued HT. In the summer of 2002, the Women’s Health Initiative (WHI) randomized trial … [Read more...] about WHI Estrogen-Plus-Progestin Trial…
Archives for March 2008
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
JAMA Publishes HRT Study JAMA. 2008;299(9):1036-1045. Context: The Women's Health Initiative (WHI) trial of estrogen plus progestin vs placebo was stopped early, after a mean 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its … [Read more...] about Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
The Women's Health Initiative (WHI) Trial Team Gerardo Heiss, MD; Robert Wallace, MD; Garnet L. Anderson, PhD; Aaron Aragaki, MS; Shirley A. A. Beresford, PhD; Robert Brzyski, MD; Rowan T. Chlebowski, MD; Margery Gass, MD; Andrea LaCroix, PhD; JoAnn E. Manson, MD; Ross L. … [Read more...] about Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
FDA Fiddles
While Wyeth Wrings Profits From Womens BodiesHere's some news that will make us all depressed - Wyeth has won FDA approval for its new antidepressant Pristiq. Yes, the same FDA who has just told us "bioidentical hormones" don't exist, the same FDA who has told compounding … [Read more...] about FDA Fiddles